purinergic receptor modulators (Adamed)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namepurinergic receptor modulators (Adamed)
Drug Alias NameP2Y12 and P2Y1 targeting agents (Adamed)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionP2Y purinoceptor 1 modulatorsCoagulation factor inhibitorsPurinergic receptor P2Y12 modulators
TargetsP2Y purinoceptor 1Coagulation factorPurinergic receptor P2Y12
Therapy Area/IndicationsThrombosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryPoland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAdamed
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAdamed
Active IndicationsN/A
Inactive IndicationsThrombosis

Other Information

ATC CodeN/A
Related LinksN/A